Iti Pharma And Healthcare Fund Datagrid
Category Sectoral/ Thematic
BMSMONEY Rank 15
Rating
Growth Option 12-02-2026
NAV ₹15.2(R) -0.45% ₹16.57(D) -0.45%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular -1.38% 18.65% -% -% -%
Direct 0.5% 20.98% -% -% -%
Nifty 500 TRI 14.19% 17.78% 14.76% 16.15% 16.32%
SIP (XIRR) Regular -8.14% 9.02% -% -% -%
Direct -6.34% 11.25% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.81 0.4 0.72 3.4% 0.14
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.58% -18.89% -16.32% 0.92 11.17%
Fund AUM As on: 30/12/2025 230 Cr
Top Sectoral/ Thematic
Fund Name Rank Rating
Icici Prudential India Opportunities Fund 1
ICICI Prudential Business Cycle Fund 2
Icici Prudential Exports And Services Fund 3
Aditya Birla Sun Life Special Opportunities Fund 4
Franklin India Opportunities Fund 5

NAV Date: 12-02-2026

Scheme Name NAV Rupee Change Percent Change
ITI Pharma and Healthcare Fund - Regular Plan - IDCW Option 15.2
-0.0700
-0.4500%
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 15.2
-0.0700
-0.4500%
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option 16.57
-0.0700
-0.4500%
ITI Pharma and Healthcare Fund - Direct Plan - IDCW Option 16.57
-0.0700
-0.4500%

Review Date: 12-02-2026

Beginning of Analysis

ITI Pharma and Healthcare Fund is the 12th ranked fund in the Sectoral/ Thematic Fund category. The category has total 22 funds. The ITI Pharma and Healthcare Fund has shown an average past performence in Sectoral/ Thematic Fund. The fund has a Jensen Alpha of 3.4% which is higher than the category average of 1.71%. Here the fund has shown good performance in terms of risk adjusted returns. The fund has a Sharpe Ratio of 0.81 which is lower than the category average of 0.85.
The past performance of the fund may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds. The ranking is based on proprietary methodology developed by bmsmoney. The methodology is based on the past performance of the funds and does not guarantee future performance.
Sectoral/Thematic Mutual Funds are ideal for aggressive investors seeking high returns by investing in a specific sector or theme. These funds offer targeted exposure to sectors like banking, technology, or themes like infrastructure and ESG, allowing investors to capitalize on the growth potential of these segments. However, they carry higher risks due to their concentrated exposure and are heavily dependent on the performance of the chosen sector or theme. Investors should have a long-term investment horizon, a high risk tolerance, and a good understanding of the sector or theme before investing in these funds. Additionally, timing the market and monitoring sectoral trends are crucial for success.

ITI Pharma and Healthcare Fund Return Analysis

The ITI Pharma and Healthcare Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Sectoral/ Thematic Fund peers and the Nifty 500 TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Sectoral/ Thematic Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -1.91%, -6.34 and -5.05 in last one, three and six months respectively. In the same period the category average return was 1.23%, -0.36% and 4.89% respectively.
  • ITI Pharma and Healthcare Fund has given a return of 0.5% in last one year. In the same period the Nifty 500 TRI return was 14.19%. The fund has given 13.69% less return than the benchmark return.
  • The fund has given a return of 20.98% in last three years and rank 8th out of 23 funds in the category. In the same period the Nifty 500 TRI return was 17.78%. The fund has given 3.2% more return than the benchmark return.
  • The fund has given a SIP return of -6.34% in last one year whereas category average SIP return is 8.59%. The fund one year return rank in the category is 30th in 32 funds
  • The fund has SIP return of 11.25% in last three years and ranks 14th in 21 funds. Franklin India Opportunities Fund has given the highest SIP return (21.24%) in the category in last three years.

ITI Pharma and Healthcare Fund Risk Analysis

  • The fund has a standard deviation of 15.58 and semi deviation of 11.17. The category average standard deviation is 13.32 and semi deviation is 9.69.
  • The fund has a Value at Risk (VaR) of -18.89 and a maximum drawdown of -16.32. The category average VaR is -16.57 and the maximum drawdown is -18.01. The fund has a beta of 0.87 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Sectoral/ Thematic Fund Category
  • Good Performance in Sectoral/ Thematic Fund Category
  • Poor Performance in Sectoral/ Thematic Fund Category
  • Very Poor Performance in Sectoral/ Thematic Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty 500 TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -2.07 0.69
    1.13
    		-2.13 | 6.10 33 | 34 Poor
    3M Return % -6.79 -0.67
    -0.66
    		-6.79 | 7.75 34 | 34 Poor
    6M Return % -5.95 5.12
    4.27
    		-6.65 | 21.08 32 | 33 Poor
    1Y Return % -1.38 14.19
    12.86
    		-9.47 | 37.90 32 | 33 Poor
    3Y Return % 18.65 17.78
    18.61
    		11.00 | 30.25 11 | 23 Good
    1Y SIP Return % -8.14
    7.29
    		-9.62 | 37.82 30 | 32 Poor
    3Y SIP Return % 9.02
    12.08
    		4.62 | 19.68 16 | 22 Average
    Standard Deviation 15.58
    13.32
    		11.05 | 16.95 20 | 22 Poor
    Semi Deviation 11.17
    9.69
    		7.88 | 13.09 21 | 22 Poor
    Max Drawdown % -16.32
    -18.01
    		-24.21 | -12.71 7 | 22 Good
    VaR 1 Y % -18.89
    -16.57
    		-26.24 | -9.87 15 | 22 Average
    Average Drawdown % -7.15
    -6.16
    		-9.49 | -3.84 17 | 22 Average
    Sharpe Ratio 0.81
    0.85
    		0.49 | 1.50 10 | 22 Good
    Sterling Ratio 0.72
    0.64
    		0.39 | 1.07 7 | 22 Good
    Sortino Ratio 0.40
    0.43
    		0.23 | 0.78 9 | 22 Good
    Jensen Alpha % 3.40
    1.71
    		-2.83 | 12.24 7 | 22 Good
    Treynor Ratio 0.14
    0.12
    		0.07 | 0.22 6 | 22 Very Good
    Modigliani Square Measure % 15.70
    17.18
    		12.47 | 26.00 12 | 22 Good
    Alpha % 2.22
    1.17
    		-3.52 | 14.14 8 | 22 Good
    Return data last Updated On : Feb. 12, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2025
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty 500 TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -1.91 0.69 1.23 -2.03 | 6.20 33 | 34 Poor
    3M Return % -6.34 -0.67 -0.36 -6.34 | 8.04 34 | 34 Poor
    6M Return % -5.05 5.12 4.89 -5.97 | 21.70 32 | 33 Poor
    1Y Return % 0.50 14.19 14.20 -8.22 | 39.31 32 | 33 Poor
    3Y Return % 20.98 17.78 19.95 12.37 | 31.78 8 | 23 Good
    1Y SIP Return % -6.34 8.59 -8.38 | 39.27 30 | 32 Poor
    3Y SIP Return % 11.25 13.56 5.97 | 21.24 14 | 21 Average
    Standard Deviation 15.58 13.32 11.05 | 16.95 20 | 22 Poor
    Semi Deviation 11.17 9.69 7.88 | 13.09 21 | 22 Poor
    Max Drawdown % -16.32 -18.01 -24.21 | -12.71 7 | 22 Good
    VaR 1 Y % -18.89 -16.57 -26.24 | -9.87 15 | 22 Average
    Average Drawdown % -7.15 -6.16 -9.49 | -3.84 17 | 22 Average
    Sharpe Ratio 0.81 0.85 0.49 | 1.50 10 | 22 Good
    Sterling Ratio 0.72 0.64 0.39 | 1.07 7 | 22 Good
    Sortino Ratio 0.40 0.43 0.23 | 0.78 9 | 22 Good
    Jensen Alpha % 3.40 1.71 -2.83 | 12.24 7 | 22 Good
    Treynor Ratio 0.14 0.12 0.07 | 0.22 6 | 22 Very Good
    Modigliani Square Measure % 15.70 17.18 12.47 | 26.00 12 | 22 Good
    Alpha % 2.22 1.17 -3.52 | 14.14 8 | 22 Good
    Return data last Updated On : Feb. 12, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Dec. 31, 2025
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Iti Pharma And Healthcare Fund NAV Regular Growth Iti Pharma And Healthcare Fund NAV Direct Growth
    12-02-2026 15.2036 16.5685
    11-02-2026 15.2726 16.6429
    10-02-2026 15.0687 16.4199
    09-02-2026 15.0231 16.3693
    06-02-2026 14.7802 16.1021
    05-02-2026 14.8743 16.2038
    04-02-2026 14.9225 16.2555
    03-02-2026 14.9558 16.291
    02-02-2026 14.5531 15.8515
    30-01-2026 14.6772 15.9842
    29-01-2026 14.4974 15.7876
    28-01-2026 14.6527 15.9559
    27-01-2026 14.629 15.9292
    23-01-2026 14.7041 16.0077
    22-01-2026 14.8855 16.2044
    21-01-2026 14.73 16.0343
    20-01-2026 14.8515 16.1657
    19-01-2026 15.2072 16.552
    16-01-2026 15.3278 16.6807
    14-01-2026 15.477 16.8414
    13-01-2026 15.5144 16.8812
    12-01-2026 15.5243 16.8911

    Fund Launch Date: 17/Nov/2021
    Fund Category: Sectoral/ Thematic
    Investment Objective: The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
    Fund Description: An open ended equity scheme investing in Pharma and Healthcare
    Fund Benchmark: Nifty Healthcare Total Return Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.